Esophageal dysfunction in scleroderma: relationship with disease subsets

Area of Science:

• Gastroenterology
• Rheumatology
• Clinical Medicine

Background:

• Scleroderma (systemic sclerosis) is an autoimmune disease characterized by fibrosis affecting the skin and internal organs.
• Gastrointestinal (GI) dysmotility is a common and often debilitating complication of scleroderma.
• Understanding the relationship between disease extent and GI involvement is crucial for patient management.

Purpose of the Study:

• To investigate the link between esophageal function and scleroderma disease extent.
• To examine gastric and small bowel motility in patients with severe scleroderma manifestations.

Main Methods:

• Esophageal function assessed in 125 scleroderma patients using radiology, endoscopy, manometry, and pH-metry.
• Gastrointestinal manometry performed on 10 patients during fasting and post-meal states.
• Antroduodenal manometry utilized to evaluate gastric and small bowel motility.

Main Results:

• Esophageal abnormalities found in a high percentage of patients (radiologic: 68%, esophagitis: 36%, manometric: 80%, pathologic reflux: 78%).
• Endoscopic esophagitis incidence correlated significantly with more severe cutaneous involvement (Type III).
• Manometric abnormalities severity strongly correlated with overall disease severity; antroduodenal manometry revealed high rates of neuropathic (60%) and myopathic (30%) patterns in severe disease.

Conclusions:

• A direct relationship exists between scleroderma subsets and the severity of esophageal and distal gut motor involvement.
• Esophageal manometry is the most critical diagnostic tool for assessing GI disease severity in scleroderma.
• Gastric and small bowel manometry can identify widespread gut involvement, aiding in therapeutic strategy development.